Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions

Recently, IVX Health announced the opening of three new Tampa-based infusion centers to treat patients with chronic conditions. Currently, IVX Health, who describes themselves as "[providing] biologic injections and infusions…

Continue Reading IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions
Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
source: pixabay.com

Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory

by Caitlin Seida from In The Cloud Copy Those living with autoimmune disorders like uveitis and multiple sclerosis know all too well that the cells within our bodies meant to…

Continue Reading Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
source: pixabay.com

Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases

  According to an article in Science Alert first published in the journal The Conversation, researchers at the University of Birmingham have shown that it is possible to prevent the…

Continue Reading Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
Moebius Syndrome Patient Explains How to Emote While Wearing a Mask
source: pixabay.com

Moebius Syndrome Patient Explains How to Emote While Wearing a Mask

Moebius Syndrome Moebius syndrome is a rare condition that causes an inability to move the eyes laterally and facial paralysis. A similar type of paralysis can also occur as a…

Continue Reading Moebius Syndrome Patient Explains How to Emote While Wearing a Mask
How Rogue Astrocytes Cause Neurodegeneration
GerryShaw / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

How Rogue Astrocytes Cause Neurodegeneration

  You have a number of different cells throughout your body, all of which perform different functions or provide support. One extremely interesting type are astrocytes, star-shaped glial cells that…

Continue Reading How Rogue Astrocytes Cause Neurodegeneration
1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
source: pixabay.com

1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases

Leszek Ignatowicz, a researcher from Georgia State University, recently received a 5 year, almost 2 million dollar grant from the NIH for his investigation into multiple sclerosis (MS). This project…

Continue Reading 1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment
source: pixabay.com

Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

According to a story from Multiple Sclerosis News Today, the drug company Bristol-Myers Squibb recently announced that its drug ozanimod (marketed as Zeposia) is now available for public use in…

Continue Reading Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis

The European Commission has recently granted approval to Bristol Myers Squibb (BMS) for their multiple sclerosis (MS) treatment, Zeposia. It has already been approved by the FDA in the US…

Continue Reading Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

Scientists Have Discovered a New Approach to Diagnosing Multiple Sclerosis

Scientists at the Tohoku University reported in Asia Research News that antibodies are responsible for the difference between various disorders and multiple sclerosis (MS). These disorders affect the myelin sheath…

Continue Reading Scientists Have Discovered a New Approach to Diagnosing Multiple Sclerosis
A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training
Photo by Dingzeyu Li on Unsplash

A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training

Being at peace with ourselves and our lives makes daily living so much easier. Of course, sometimes it's easier said than done. But one tactic may help improve comfort, confidence,…

Continue Reading A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training
A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
source: pixabay.com

A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!

Edwin Chapman, who works at the University of Wisconsin-Madison, has been studying neurons for most of his career. He and his team recently made a discovery regarding SYT1-associated neurodevelopmental disorder.…

Continue Reading A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
ANCA Vasculitis Could Be Severe Complication of Lemtrada
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

ANCA Vasculitis Could Be Severe Complication of Lemtrada

According to ANCA Vasculitis News, recent research shows that patients with multiple sclerosis who are being treated with Lemtrada are at greater risk of developing severe ANCA vasculitis. The drug therapy…

Continue Reading ANCA Vasculitis Could Be Severe Complication of Lemtrada
New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Science!

New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica

  Technological advancement throughout the world will ultimately lead to new ideas and strategies within the medical realm. As reported by Azo Sensors, a team of Brazilian researchers is already…

Continue Reading New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Close Menu